Sana Biotechnology Inc SANA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
4.13UNCH (UNCH)
Volume
23,742
Close
4.13quote price arrow down-0.30 (-6.77%)
Volume
581,340
52 week range
3.92 - 19.69
Loading...
  • Open4.43
  • Day High4.43
  • Day Low4.10
  • Prev Close4.43
  • 52 Week High19.69
  • 52 Week High Date12/09/21
  • 52 Week Low3.92
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap787.71M
  • Shares Out190.73M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-73.32

KEY STATS

  • Open4.43
  • Day High4.43
  • Day Low4.10
  • Prev Close4.43
  • 52 Week High19.69
  • 52 Week High Date12/09/21
  • 52 Week Low3.92
  • 52 Week Low Date06/14/22
  • Market Cap787.71M
  • Shares Out190.73M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-73.32

RATIOS/PROFITABILITY

  • EPS (TTM)-1.61
  • P/E (TTM)-2.57
  • Fwd P/E (NTM)-1.63
  • EBITDA (TTM)-287.225M
  • ROE (TTM)-42.94%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/14/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sana Biotechnology Inc

 

Profile

MORE
Sana Biotechnology, Inc. is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing...
Richard Mulligan Ph.D.
Executive Vice Chairman of the Board and Head of SanaX
Hans Bishop
Independent Chairman of the Board